Investor Relations

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact

Second quarter 2023 results

Second quarter 2023 results were reviewed by management during a live audio webcast with the financial community. The presentation were followed by a Q&A session.

14:30 -16:00 CET | 8:30am – 10am EST

Upcoming events

27Oct

2023

Third quarter 2023 results

Third quarter 2023 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

Discover more

30Apr

2024

General Meeting 2024

The Sanofi General Meeting will be held on April 30, 2024 at 14h30 (CET).

14:30 - 16:30

Annual General Meeting (AGM)

Discover more

Press releases

September 26, 2023
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
September 25, 2023
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
September 22, 2023
Press Release: Availability of the Q3 2023 Memorandum for modelling purposes
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com

Latest publications

Half Year 2023 Financial Report
Download PDF
Half Year 2023 Financial Report XBRL Package
Download PDF
First quarter 2023 results
Download PDF
Fourth quarter and full year 2022 results
Download PDF